12.06.2014 • News

Former Novartis Employee Suspected of Data Manipulation

A former employee of Novartis Pharma KK, the Japan unit of the Swiss drugmaker, has been arrested on suspicion of manipulating data to promote the company's best-selling blood pressure drug Diovan.

Nobuo Shiraishi is suspected of violating Japan's pharmaceutical laws by providing false data to researchers, whose work was intended for use in advertising the drug, the Tokyo District Public Prosecutor's Office said in a statement.

Novartis Pharma KK said it would cooperate with the investigation.

Anyone found guilty of exaggerated advertising of drugs in Japan can be punished with up to two years in prison or a fine of as much as 2 million yen ($19,600), or both.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.